SwePub - search: WFRF:(Tardif JC)

Enumeration	Reference	Cover	Find
1.	Ridker, PM, et al. (author) Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients 2017 In: The New England journal of medicine. - 1533-4406 .- 0028-4793. ; 376:16, s. 1527-1539 Journal article (peer-reviewed)
2.	Wood, AR, et al. (author) Defining the role of common variation in the genomic and biological architecture of adult human height 2014 In: Nature genetics. - : Springer Science and Business Media LLC. - 1546-1718 .- 1061-4036. ; 46:11, s. 1173-1186 Journal article (peer-reviewed)
3.	Graham, SE, et al. (author) Author Correction: The power of genetic diversity in genome-wide association studies of lipids 2023 In: Nature. - 1476-4687. ; 618:7965, s. E19-E20 Journal article (other academic/artistic)
4.	Graham, SE, et al. (author) The power of genetic diversity in genome-wide association studies of lipids 2021 In: Nature. - : Springer Science and Business Media LLC. - 1476-4687 .- 0028-0836. ; 600:7890, s. 675- Journal article (peer-reviewed)
5.	Liu, DJ, et al. (author) Exome-wide association study of plasma lipids in >300,000 individuals 2017 In: Nature genetics. - : Springer Science and Business Media LLC. - 1546-1718 .- 1061-4036. ; 49:12, s. 1758- Journal article (peer-reviewed)
6.	Winkler, TW, et al. (author) Correction: The Influence of Age and Sex on Genetic Associations with Adult Body Size and Shape: A Large-Scale Genome-Wide Interaction Study 2016 In: PLoS genetics. - : Public Library of Science (PLoS). - 1553-7404 .- 1553-7390. ; 12:6, s. e1006166- Journal article (peer-reviewed)
7.	Winkler, TW, et al. (author) The Influence of Age and Sex on Genetic Associations with Adult Body Size and Shape: A Large-Scale Genome-Wide Interaction Study 2015 In: PLoS genetics. - : Public Library of Science (PLoS). - 1553-7404 .- 1553-7390. ; 11:10, s. e1005378- Journal article (peer-reviewed)
8.	den Hoed, Marcel, et al. (author) Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders 2013 In: Nature genetics. - : Springer Science and Business Media LLC. - 1546-1718 .- 1061-4036. ; 45:6, s. 621- Journal article (peer-reviewed)
9.	Yengo, L, et al. (author) A saturated map of common genetic variants associated with human height 2022 In: Nature. - : Springer Science and Business Media LLC. - 1476-4687 .- 0028-0836. ; 610:7933, s. 704- Journal article (peer-reviewed)
10.	Patel, RS, et al. (author) Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events 2019 In: Circulation. Genomic and precision medicine. - 2574-8300. ; 12:4, s. e002471- Journal article (peer-reviewed)
11.	Patel, RS, et al. (author) Subsequent Event Risk in Individuals With Established Coronary Heart Disease 2019 In: Circulation. Genomic and precision medicine. - 2574-8300. ; 12:4, s. e002470- Journal article (peer-reviewed)
12.	Bentley-Lewis, R, et al. (author) Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo 2015 In: American heart journal. - : Elsevier BV. - 1097-6744 .- 0002-8703. ; 169:5, s. 631-U75 Journal article (peer-reviewed)
13.	Lincoff, AM, et al. (author) Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trial 2014 In: JAMA. - : American Medical Association (AMA). - 1538-3598 .- 0098-7484. ; 311:15, s. 1515-1525 Journal article (peer-reviewed)
14.	Lincoff, AM, et al. (author) Evaluation of the dual peroxisome proliferator-activated receptor α/γ agonist aleglitazar to reduce cardiovascular events in patients with acute coronary syndrome and type 2 diabetes mellitus: rationale and design of the AleCardio trial 2013 In: American heart journal. - : Elsevier BV. - 1097-6744 .- 0002-8703. ; 166:3, s. 429- Journal article (peer-reviewed)
15.	Morici, N, et al. (author) Post-Discharge Worsening Renal Function in Patients with Type 2 Diabetes and Recent Acute Coronary Syndrome 2017 In: The American journal of medicine. - : Elsevier BV. - 1555-7162 .- 0002-9343. ; 130:9, s. 1068-1075 Journal article (peer-reviewed)
16.	Nicholls, SJ, et al. (author) Diabetic dyslipidemia: extending the target beyond LDL cholesterol 2010 In: European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology. - : Oxford University Press (OUP). - 1741-8275. ; 1717 Suppl 1, s. S20-S24 Journal article (peer-reviewed)
17.	Pfeffer, MA, et al. (author) Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome 2015 In: The New England journal of medicine. - 1533-4406. ; 373:23, s. 2247-2257 Journal article (peer-reviewed)
18.	Ridker, PM, et al. (author) Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab 2017 In: The New England journal of medicine. - 1533-4406. ; 376:16, s. 1517-1526 Journal article (peer-reviewed)
19.	Rosenson, RS, et al. (author) HDL and atherosclerotic cardiovascular disease: genetic insights into complex biology 2018 In: Nature reviews. Cardiology. - : Springer Science and Business Media LLC. - 1759-5010 .- 1759-5002. ; 15:1, s. 9-19 Journal article (peer-reviewed)
20.	Savonitto, S, et al. (author) Impact of age on the predictive value of NT-proBNP in patients with diabetes mellitus stabilised after an acute coronary syndrome 2024 In: Diabetes research and clinical practice. - 1872-8227. ; 208, s. 111112- Journal article (peer-reviewed)
21.	Savonitto, S, et al. (author) Predictors of mortality in hospital survivors with type 2 diabetes mellitus and acute coronary syndromes 2018 In: Diabetes & vascular disease research. - : SAGE Publications. - 1752-8984 .- 1479-1641. ; 15:1, s. 14-23 Journal article (peer-reviewed)
22.	Tardif, JC, et al. (author) Anti-anginal and anti-ischaemic effects of the If current inhibitor ivabradine in patients with stable angina pectoris receiving beta-blockers. A 4-month randomised, double-blind, multicenter trial 2008 In: EUROPEAN HEART JOURNAL. - 0195-668X. ; 29, s. 386-387 Conference paper (other academic/artistic)
23.	Tardif, JC, et al. (author) Anti-anginal and anti-ischaemic effects of the If current inhibitor ivabradine in patients with stable angina pectoris receiving standard doses of beta-blockers. A 4-month randomised, double-blind, multicenter trial 2008 In: FUNDAMENTAL & CLINICAL PHARMACOLOGY. - 0767-3981. ; 22, s. 96-96 Conference paper (other academic/artistic)
24.	Tardif, JC, et al. (author) Effects of ivabradine in patients with stable angina receiving β-blockers according to baseline heart rate: an analysis of the ASSOCIATE study 2013 In: International journal of cardiology. - : Elsevier BV. - 1874-1754 .- 0167-5273. ; 168:2, s. 789-794 Journal article (peer-reviewed)
25.	Tardif, JC, et al. (author) Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial 2009 In: European heart journal. - : Oxford University Press (OUP). - 1522-9645 .- 0195-668X. ; 30:5, s. 540-548 Journal article (peer-reviewed)

Skapa referenser, mejla, bekava och länka

Permalink

Träfflista för sökning "WFRF:(Tardif JC) "

Refine your search

Year